|
|
Post by hellodolly on Feb 3, 2023 13:32:49 GMT -5
re: Verona It appears that the only competition would be against MNKD-301, dornase alfa, for cystic fibrosis. UTHR, at least for the present, has dropped COPD. Nothing is in MNKD pipeline for asthma. VRNA's CEO said during an investor presentation there's research out there that states patients prefer Nebulizers because there's very little effort in the mechanics of breathing. He said with DPI there's a technique (ie hand coordination) in administering the drug and can cause problems. He said patients like the simplicity of nebulizers. If that's the case then why are they developing DPI Drugs? He also said Nebulizers have a higher pricing point. He said Nebulizers are priced between $1,100 - $1,200 a month vs. DPI at $500 a month. VRNAs CEO is mixing a study on the ease of use of nebulizers with what? There are no head-to-head studies that compare the nebulizer with MNKD's cricket, for example. VRNA may have qualitative data only (as does UTHR) on preference and nothing about comparing the dexterity (ie hand coordination) [ This CEO is smoking crack and trying to sell ice to Eskimos]. In fact, UTHR clinical patients inferred just the opposite. They preferred the dry powder device compared to the nebulizer. Why? Because it gives them the freedom and flexibility to live their life without being tied down to the nebulizer, plus as was mentioned it's convenience and ease of use. Translation...better quality of life. VRNAs CEO can't do better than talk about dexterity. [See my Eskimo comment above]LQDAs CEO tried commingling facts by doing something similar when he stated that their delivery device was preferred by patients taking the DPI version of Yutrepia over Treprostinil, but left out that it was compared to the nebulize version of Treprostinil and not Tyvaso, DPI. Jokers...have to be careful with what they say. |
|
|
|
Post by porkini on Feb 3, 2023 14:41:01 GMT -5
Also, doesn't a nebuliser breathing treatment take 5-10 minutes to complete a single treatment ? And you can't throw it in your purse and use it anywhere you want. The advantages to not needing a nebulizer could be much bigger than I initially thought. Or perhaps, murse?  |
|
|
|
Post by BD on Feb 5, 2023 11:51:38 GMT -5
Never heard the word "murse", but that's definitely not for me...one more opportunity to space out and leave my belongings somewhere???
|
|
|
|
Post by porkini on Feb 5, 2023 12:45:15 GMT -5
"murse" = slang, man purse
|
|
|
|
Post by BD on Feb 5, 2023 12:47:13 GMT -5
Right, I had to Google it.
|
|
|
|
Post by casualinvestor on Feb 6, 2023 10:06:19 GMT -5
|
|
|
|
Post by BD on Feb 6, 2023 16:41:53 GMT -5
|
|
|
|
Post by dddupont on Feb 17, 2023 15:03:06 GMT -5
Sorry if this is the wrong thread, or if it has been answered already…
How long does MNKD need to stay above $5.00 to be added back into relevant index funds?
Would such an event add volume and potential price gains?
Thanks in advance for any info!
|
|
|
|
Post by peppy on Feb 17, 2023 15:37:55 GMT -5
Sorry if this is the wrong thread, or if it has been answered already… How long does MNKD need to stay above $5.00 to be added back into relevant index funds? Would such an event add volume and potential price gains? Thanks in advance for any info! scroll down as well. IBB holds 11 million shares. |
|
|
|
Post by dddupont on Feb 17, 2023 15:48:59 GMT -5
Sorry if this is the wrong thread, or if it has been answered already… How long does MNKD need to stay above $5.00 to be added back into relevant index funds? Would such an event add volume and potential price gains? Thanks in advance for any info! scroll down as well. IBB holds 11 million shares. Thanks for that link! So for IBB is there no stock price minimum to be included in that ETF? What about other funds, do they have minimum PPS? |
|
|
|
Post by cretin11 on Feb 17, 2023 16:38:17 GMT -5
The so-called "$5 rule" is mostly a myth. Mutual funds and institutional investors have no prohibition on including stocks priced below $5 per share. They can choose to avoid them if they want, but there's no mandatory minimum PPS.
|
|
|
|
Post by agedhippie on Feb 17, 2023 18:33:56 GMT -5
... IBB holds 11 million shares. Thanks for that link! So for IBB is there no stock price minimum to be included in that ETF? What about other funds, do they have minimum PPS? The ETF holding are defined by the tracker. IBB tracks the stocks in the biotech sector so they buy every stock in that sector. The number is set by the rules of the ETF,; some want equal dollar weighting, others want a percentage that reflects their value market cap in the sector. For these funds PPS is unimportant and they are purely mechanical purchasers. |
|
|
|
Post by sportsrancho on Feb 18, 2023 8:47:08 GMT -5
In my landlords account, he has several, his retirement account won’t let him buy stocks under $10 …his Merrill account won’t let him buy stocks under $3.
I find it best to trade in TD Ameritrade :-)
|
|
|
|
Post by prcgorman2 on Feb 24, 2023 17:59:11 GMT -5
The so-called "$5 rule" is mostly a myth. Mutual funds and institutional investors have no prohibition on including stocks priced below $5 per share. They can choose to avoid them if they want, but there's no mandatory minimum PPS.
"Stocks that trade below $5 are considered so risky that institutional investors, including pensions and mutual funds, aren't allowed to buy penny stocks and can even be required to sell securities that fall below the $5 mark. This double-edged sword cuts both ways, however, when an issue rises above $5 and institutions are allowed to buy."
|
|
|
|
Post by cretin11 on Feb 25, 2023 10:29:13 GMT -5
The so-called "$5 rule" is mostly a myth. Mutual funds and institutional investors have no prohibition on including stocks priced below $5 per share. They can choose to avoid them if they want, but there's no mandatory minimum PPS.
"Stocks that trade below $5 are considered so risky that institutional investors, including pensions and mutual funds, aren't allowed to buy penny stocks and can even be required to sell securities that fall below the $5 mark. This double-edged sword cuts both ways, however, when an issue rises above $5 and institutions are allowed to buy." Even that author fell for the myth. Here’s a more recent (and informed) link: finance.yahoo.com/news/3-myths-penny-stocks-150213321.html“Myth #3: Institutions cannot trade penny stocks Many people assume that the penny stock market is made up entirely of retail traders and that institutions are prohibited from participating in the market, but this is actually not the case. This myth may have gained credence based on historical restrictions or prohibitions on OTC stocks, but these are no longer true. Institutions follow opportunity—be that in penny stocks or larger, more liquid securities. Importantly the majority of dollar volume traded occurs in the 3400+ OTC securities which meet the penny stock exemption, including ADR's, Banks, Fannie Mae and Freddie Mac. Clarifying the misconceptions around what constitutes a penny stock and understanding the data is critical to helping retail investors and institutions make better-informed decisions.” |
|
